Works matching AU Numakura, Kazuyuki

Results: 107
    1

    Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real‐World Multicenter Study.

    Published in:
    International Journal of Urology, 2025, v. 32, n. 6, p. 679, doi. 10.1111/iju.70030
    By:
    • Ozaki, Kai;
    • Yamamoto, Hayato;
    • Sekine, Yuya;
    • Horiguchi, Hirotaka;
    • Hosogoe, Shogo;
    • Mikami, Jotaro;
    • Fujita, Naoki;
    • Tokui, Noriko;
    • Okita, Kazutaka;
    • Okamoto, Teppei;
    • Mori, Kanami;
    • Kobayashi, Mizuki;
    • Numakura, Kazuyuki;
    • Yoneyama, Takahiro;
    • Tabata, Ryuji;
    • Sato, Satoshi;
    • Habuchi, Tomonori;
    • Ohyama, Chikara;
    • Hatakeyama, Shingo
    Publication type:
    Article
    2

    Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 531, doi. 10.1093/jjco/hyaf018
    By:
    • Kikuchi, Hiroshi;
    • Osawa, Takahiro;
    • Matsushita, Yuto;
    • Kojima, Takahiro;
    • Sazuka, Tomokazu;
    • Hatakeyama, Shingo;
    • Goto, Keisuke;
    • Numakura, Kazuyuki;
    • Yamana, Kazutoshi;
    • Kandori, Shuya;
    • Ueda, Kosuke;
    • Tanaka, Hajime;
    • Kurahashi, Toshifumi;
    • Bando, Yukari;
    • Kimura, Takahiro;
    • Nishiyama, Naotaka;
    • Kato, Takuma;
    • Hara, Hiroaki;
    • Ito, Yoichi;
    • Kitamura, Hiroshi
    Publication type:
    Article
    3

    Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 204, doi. 10.1007/s10147-011-0275-6
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Maita, Shinya;
    • Obara, Takashi;
    • Numakura, Kazuyuki;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Habuchi, Tomonori
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 192, doi. 10.1093/jjco/hyad155
    By:
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Miyake, Makito;
    • Miyata, Haruka;
    • Matsumoto, Ryuji;
    • Osawa, Takahiro;
    • Nishimura, Nobutaka;
    • Fujimoto, Kiyohide;
    • Inokuchi, Junichi;
    • Yoneyama, Takahiro;
    • Tomida, Ryotaro;
    • Numakura, Kazuyuki;
    • Matsushita, Yuto;
    • Matsumoto, Kazumasa;
    • Sato, Takuma;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka
    Publication type:
    Article
    13

    Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1441, doi. 10.1093/jjco/hyac141
    By:
    • Sekine, Yuya;
    • Iwasaki, Yusuke;
    • Hakozaki, Nozomi;
    • Endo, Mikiko;
    • Kamatani, Yoichiro;
    • Matsuda, Koichi;
    • Murakami, Yoshinori;
    • Sano, Takeshi;
    • Akamatsu, Shusuke;
    • Kobayashi, Takashi;
    • Nakagawa, Hidewaki;
    • Numakura, Kazuyuki;
    • Narita, Shintaro;
    • Habuchi, Tomonori;
    • Momozawa, Yukihide
    Publication type:
    Article
    14
    15

    Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1770, doi. 10.1093/jjco/hyab161
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    16

    Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 11, p. 1656, doi. 10.1093/jjco/hyab114
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    17
    18
    19

    Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2025.102322
    By:
    • Takahashi, Masayuki;
    • Matsushita, Yuto;
    • Kojima, Takahiro;
    • Osawa, Takahiro;
    • Sazuka, Tomokazu;
    • Hatakeyama, Shingo;
    • Goto, Keisuke;
    • Numakura, Kazuyuki;
    • Yamana, Kazutoshi;
    • Kandori, Shuya;
    • Fujita, Kazutoshi;
    • Ueda, Kosuke;
    • Tanaka, Hajime;
    • Tomida, Ryotaro;
    • Kurahashi, Toshifumi;
    • Bando, Yukari;
    • Kimura, Takahiro;
    • Nishiyama, Naotaka;
    • Yamashita, Shimpei;
    • Taniguchi, Hisanori
    Publication type:
    Article
    20
    21
    22
    23
    24

    Altered miRNA expression in high-fat diet-induced prostate cancer progression.

    Published in:
    Carcinogenesis, 2016, v. 37, n. 12, p. 1229, doi. 10.1093/carcin/bgw108
    By:
    • Taketoshi Nara;
    • Shintaro Narita;
    • Huang Mingguo;
    • Toshiaki Yoshioka;
    • Atsushi Koizumi;
    • Kazuyuki Numakura;
    • Hiroshi Tsuruta;
    • Atsushi Maeno;
    • Mitsuru Saito;
    • Takamitsu Inoue;
    • Norihiko Tsuchiya;
    • Shigeru Satoh;
    • Tomonori Habuchi
    Publication type:
    Article
    25
    26
    27
    28
    29

    Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48087-4
    By:
    • Sazuka, Tomokazu;
    • Matsushita, Yuto;
    • Sato, Hiroaki;
    • Osawa, Takahiro;
    • Hinata, Nobuyuki;
    • Hatakeyama, Shingo;
    • Numakura, Kazuyuki;
    • Ueda, Kosuke;
    • Kimura, Takahiro;
    • Takahashi, Masayuki;
    • Tanaka, Hajime;
    • Kawasaki, Yoshihide;
    • Kurahashi, Toshifumi;
    • Kato, Takuma;
    • Fujita, Kazutoshi;
    • Miyake, Makito;
    • Kojima, Takahiro;
    • Kitamura, Hiroshi;
    • Miyake, Hideaki;
    • Ichikawa, Tomohiko
    Publication type:
    Article
    30

    Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.

    Published in:
    Human Molecular Genetics, 2022, v. 31, n. 12, p. 1962, doi. 10.1093/hmg/ddab345
    By:
    • Sekine, Yuya;
    • Iwasaki, Yusuke;
    • Aoi, Tomomi;
    • Endo, Mikiko;
    • Hirata, Makoto;
    • Kamatani, Yoichiro;
    • Matsuda, Koichi;
    • Sugano, Kokichi;
    • Yoshida, Teruhiko;
    • Murakami, Yoshinori;
    • Fukui, Tomohiro;
    • Akamatsu, Shusuke;
    • Ogawa, Osamu;
    • Nakagawa, Hidewaki;
    • Numakura, Kazuyuki;
    • Narita, Shintaro;
    • Habuchi, Tomonori;
    • Momozawa, Yukihide
    Publication type:
    Article
    31
    32
    33

    Primary resistance to nivolumab plus ipilimumab therapy affects second‐line treatment outcomes in patients with metastatic renal cell carcinoma.

    Published in:
    Cancer Science, 2025, v. 116, n. 2, p. 444, doi. 10.1111/cas.16326
    By:
    • Mori, Kanami;
    • Numakura, Kazuyuki;
    • Matsushita, Yuto;
    • Kojima, Takahiro;
    • Osawa, Takahiro;
    • Sazuka, Tomokazu;
    • Hatakeyama, Shingo;
    • Goto, Keisuke;
    • Yamana, Kazutoshi;
    • Kandori, Shuya;
    • Kimura, Takahiro;
    • Nishiyama, Naotaka;
    • Bando, Yukari;
    • Fujita, Kazutoshi;
    • Ueda, Kosuke;
    • Tanaka, Hajime;
    • Tomida, Ryotaro;
    • Kurahashi, Toshifumi;
    • Kitamura, Hiroshi;
    • Miyake, Hideaki
    Publication type:
    Article
    34

    Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4059, doi. 10.1111/cas.15488
    By:
    • Takahashi, Shuhei;
    • Narita, Shintaro;
    • Fujiyama, Nobuhiro;
    • Hatakeyama, Shingo;
    • Kobayashi, Takashi;
    • Kato, Renpei;
    • Naito, Sei;
    • Sakatani, Toru;
    • Kashima, Soki;
    • Koizumi, Atsushi;
    • Yamamoto, Ryohei;
    • Nara, Taketoshi;
    • Kanda, Souhei;
    • Numakura, Kazuyuki;
    • Saito, Mitsuru;
    • Obara, Wataru;
    • Tsuchiya, Norihiko;
    • Ohyama, Chikara;
    • Ogawa, Osamu;
    • Habuchi, Tomonori
    Publication type:
    Article
    35

    Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.

    Published in:
    Cancer Science, 2020, v. 111, n. 3, p. 907, doi. 10.1111/cas.14294
    By:
    • Uemura, Motohide;
    • Tomita, Yoshihiko;
    • Miyake, Hideaki;
    • Hatakeyama, Shingo;
    • Kanayama, Hiro‐omi;
    • Numakura, Kazuyuki;
    • Takagi, Toshio;
    • Kato, Tomoyuki;
    • Eto, Masatoshi;
    • Obara, Wataru;
    • Uemura, Hirotsugu;
    • Choueiri, Toni K.;
    • Motzer, Robert J.;
    • Fujii, Yosuke;
    • Kamei, Yoichi;
    • Umeyama, Yoshiko;
    • Pietro, Alessandra;
    • Oya, Mototsugu
    Publication type:
    Article
    36

    Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

    Published in:
    Cancer Science, 2012, v. 103, n. 3, p. 569, doi. 10.1111/j.1349-7006.2011.02176.x
    By:
    • Inoue, Toru;
    • Matsuura, Keiko;
    • Yoshimoto, Taichiro;
    • Nguyen, Lam Tung;
    • Tsukamoto, Yoshiyuki;
    • Nakada, Chisato;
    • Hijiya, Naoki;
    • Narimatsu, Takahiro;
    • Nomura, Takeo;
    • Sato, Fuminori;
    • Nagashima, Yoji;
    • Kashima, Kenji;
    • Hatakeyama, Shingo;
    • Ohyama, Chikara;
    • Numakura, Kazuyuki;
    • Habuchi, Tomonori;
    • Nakagawa, Masayuki;
    • Seto, Masao;
    • Mimata, Hiromitsu;
    • Moriyama, Masatsugu
    Publication type:
    Article
    37

    Treatment patterns and prognosis in patients with Bacillus Calmette–Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.

    Published in:
    World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-04834-4
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Iida, Kota;
    • Miyamoto, Tatsuki;
    • Tomida, Ryotaro;
    • Numakura, Kazuyuki;
    • Inokuchi, Junichi;
    • Yoneyama, Takahiro;
    • Okajima, Eijiro;
    • Yajima, Shugo;
    • Masuda, Hitoshi;
    • Terada, Naoki;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka;
    • Kitamura, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    38
    39
    40
    41

    Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

    Published in:
    World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 1, doi. 10.1186/1477-7819-10-1
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Kumazawa, Teruaki;
    • Maita, Shinya;
    • Numakura, Kazuyuki;
    • Obara, Takashi;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Nanjyo, Hiroshi;
    • Habuchi, Tomonori
    Publication type:
    Article
    42
    43
    44
    45

    Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.

    Published in:
    Cancers, 2023, v. 15, n. 7, p. 2002, doi. 10.3390/cancers15072002
    By:
    • Numakura, Kazuyuki;
    • Miyake, Makito;
    • Kobayashi, Mizuki;
    • Muto, Yumina;
    • Sekine, Yuya;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Shiga, Masanori;
    • Morizane, Shuichi;
    • Yoneyama, Takahiro;
    • Matsumura, Yoshiaki;
    • Abe, Takashige;
    • Yamada, Takeshi;
    • Matsumoto, Kazumasa;
    • Inokuchi, Junichi;
    • Nishiyama, Naotaka;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Kitamura, Hiroshi
    Publication type:
    Article
    46
    47
    48
    49

    The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 1019, doi. 10.1007/s10147-024-02538-8
    By:
    • Numakura, Kazuyuki;
    • Sekine, Yuya;
    • Osawa, Takahiro;
    • Naito, Sei;
    • Tokairin, Ojiro;
    • Muto, Yumina;
    • Sobu, Ryuta;
    • Kobayashi, Mizuki;
    • Sasagawa, Hajime;
    • Yamamoto, Ryohei;
    • Nara, Taketoshi;
    • Saito, Mitsuru;
    • Narita, Shintaro;
    • Akashi, Hideo;
    • Tsuchiya, Norihiko;
    • Shinohara, Nobuo;
    • Habuchi, Tomonori
    Publication type:
    Article
    50

    Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1530, doi. 10.1007/s10147-023-02394-y
    By:
    • Kobayashi, Mizuki;
    • Numakura, Kazuyuki;
    • Hatakeyama, Shingo;
    • Ishida, Toshiya;
    • Koizumi, Atsushi;
    • Tadachi, Kazuki;
    • Igarashi, Ryoma;
    • Takayama, Koichiro;
    • Muto, Yumina;
    • Sekine, Yuya;
    • Sobu, Ryuta;
    • Sasagawa, Hajime;
    • Akashi, Hideo;
    • Kashima, Soki;
    • Yamamoto, Ryohei;
    • Nara, Taketoshi;
    • Saito, Mitsuru;
    • Narita, Shintaro;
    • Ohyama, Chikara;
    • Habuchi, Tomonori
    Publication type:
    Article